The embargo on all abstracts accepted to the 2019 Gastrointestinal Cancers Symposium will lift at 5:00 p.m. ET on Monday, January 14, 2019. An embargoed presscast (virtual press briefing held via teleconference and webinar) will be held at 12:00 noon ET on January 14 for credentialed media.
Attend the Meeting in Person/Participate in the Presscast
Media registration for the 2019 Gastrointestinal Cancers Symposium will open in November. At that time, you can visit ASCO's Media Headquarters to apply for media credentials,* register to attend an upcoming meeting, access embargoed meeting information, and locate presscast dial-in information. For questions about how to navigate the site, please contact ASCO Media Registration.
*If you attended the 2018 ASCO Annual Meeting or covered the meeting remotely, you have already been credentialed by ASCO and will have access to the embargoed meeting information and the presscast. You only have to register if you want to attend the Gastrointestinal Cancers Symposium in person in San Francisco.
Access Embargoed Information
Embargoed meeting information will be made available to credentialed media through ASCO's Media Headquarters. Once your media credentials are approved, you will receive email notifications when embargoed information has been posted.
Meet the News Planning Team
2018 Gastrointestinal Cancers Symposium:
- Liquid Biopsy Test Shows Promise for Detecting Early-Stage Colorectal Cancer
ALEXANDRIA, Va. – A new study has found that a test that identifies circulating tumor cells (CTCs) present in the bloodstream can detect colorectal cancer at an early stage, with accuracy ranging from 84 to 88%. Most prior studies using CTCs have been able to detect late-stage colorectal cancer, and this study is one of the first clinical studies to show that CTCs can be useful for detecting early, more treatable stages of the cancer. Read the full release.